NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives.
J Natl Compr Canc Netw
; 9 Suppl 4: S1-22, 2011 Sep.
Article
in En
| MEDLINE
| ID: mdl-21976013
Search on Google
Database:
MEDLINE
Main subject:
Drug Approval
/
Biosimilar Pharmaceuticals
/
Antineoplastic Agents
Type of study:
Guideline
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
America do norte
/
Europa
Language:
En
Journal:
J Natl Compr Canc Netw
Journal subject:
NEOPLASIAS
Year:
2011
Type:
Article